Printer Friendly
The Free Library
19,595,263 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Alta Natural: Hepatitis C Breakthrough Now Available In Canada!; Clinical Trials Verified - Treatment to be Made Available to Sufferers.


VANCOUVER, BRITISH COLUMBIA--(BUSINESS WIRE)--Nov. 16, 1998-- Alta Natural(Alberta Stock Exchange Alberta Stock Exchange

See Canadian Venture Exchange (CDNX).
:AHS AHS Assistant House Surgeon. .) Following extensive international clinical and pre clinical trials, Alta Natural Herbs & Supplements Ltd. of Richmond, British Columbia This page is for the city of Richmond, British Columbia. For the federal electoral district in this locality see Richmond (electoral district); for the provincial electoral district see Richmond (provincial electoral district).  is pleased to announce that it will now begin distribution of Hepatico in Canada.

"One hundred and seventy million people suffer from this often fatal disease around the globe. Its impact on the population is incredibly tragic and this news today will at last offer Hep C patients the long awaited hope they've been seeking" said Alta Natural President, Adolf Huckschlag.

"Hepatico, the most promising treatment of Hepatitis C has been proven in European trials, to be effective in up to 91 per cent of tested patients." said Alta Natural medical coordinator, Doctor David Khoupenia. Alta Natural Herbs & Supplements is pleased to release independent North American studies which confirm previous European trials which are also being made public today.

Upon reviewing 17 independent reports regarding the effectiveness of Hepatico on Hep-C, Alta Natural Herbs & Supplements Ltd. launched independent human tests in Canada and the United States The United States and Canada share a unique legal relationship. U.S. law looks northward with a mixture of optimism and cooperation, viewing Canada as an integral part of U.S. economic and environmental policy. . Preliminary results have confirmed the overseas findings.

"Currently the most effective treatment for Hepatitis C is only thirty per cent successful ...and often the side effects are fatal" said Dr. Khoupenia.

Administered orally in capsule form, Hepatico is a nutraceutical product containing extracts of the nettle nettle, common name for the Urticaceae, a family of fibrous herbs, small shrubs, and trees found chiefly in the tropics and subtropics. Several genera of nettles are covered with small stinging hairs that on contact emit an irritant (formic acid) which produces a , plantain plantain (plăn`tĭn), any plant of the genus Plantago, chiefly annual or perennial weeds of wide distribution. Many species are lawn pests and the pollen is often a hay fever irritant. P.  and immortelle immortelle: see everlasting.  herbs, in combination with other naturally occurring active ingredients from the Russian Republic of Georgia.

Based upon the examination of the preliminary results and after comparisons to the European scientific data conducted between 1992 and 1996, Alta Natural Herbs & Supplements is today verifying the validity of the effectiveness of Hepatico as a primary therapy for persons suffering from toxic and viral liver dysfunction.

Hepatico will initially be available directly through Alta Natural Herbs & Supplements by calling 1-800-535-7502 and over the Internet at http://www.alta-natural.com Announcements regarding international distribution are pending.

The Alberta Stock Exchange has neither approved nor disapproved the contents of this release.
COPYRIGHT 1998 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1998, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1CANA
Date:Nov 17, 1998
Words:332
Previous Article:Complete Wellness Centers, Inc. Reports Financial Results for Third Quarter.
Next Article:Infogrames Entertainment Says Mission Accomplished; First Quarter Sales Up 43 Percent.
Topics:



Related Articles
Alta Natural: HEPATICO Tests Expanded After Positive Results, TSE and NASDAQ Listings Sought.
AIDS Research Today: 20 Views.
JOINT TESTS OF DRUGS ANNOUNCED BY FIRMS.
Late failure of combined recombinant hepatitis B vaccine and lamivudine in treatment of a patient with chronic hepatitis B.
VERTEX/MITSUBISHI TO DEVELOP HCV ORAL PROTEASE INHIBITOR.
Hepatitis coinfection: two major studies published.
Current challenges in hepatitis C.
PHARMASSET TO DEVELOP CLEVUDINE FOR HEPATITIS B.
AETHLON MEDICAL LAUNCHES HEPATITIS-C CLINICAL TRIAL.
MIGENIX INITIATES ENROLLMENT IN PHASE IIB HEPATITIS TRIAL.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles